observed in stimulation of 2-deoxyglucose uptake but not in early changes of intracellular levels of cAMP. These results may be relevant in understanding the control of fibroblastic proliferation in wound healing and may provide an alternative mechanism for oncogenic transformation.
An important property of normal animal cells is their ability to regulate the frequency of initiation of DNA replication and cell division in response to changes in the physiological and architectural requirements ofthe organism (1) (2) (3) (4) . Among the growthpromoting substances and hormones involved in modulating the regulatory mechanisms are prostaglandins (PGs) of the E and F series, which are synthesized and released by various mammalian cell types in response to different pathological and physiological changes (4) (5) (6) . Different human cancers (7) (8) (9) , chemically and virally induced tumors in animals (10, 11) , and cultured human and animal cancer cells (12, 13) produce high levels ofPGE1, PGE2, and PGF2.. Likewise, BALB/c 3T3 cells transformed by oncogenic DNA viruses exhibit increased rates of synthesis of PGE1, PGE2, and PGF2, compared with their normal counterparts (14) . In normal tissue, wound healing is accomplished mainly by the proliferation of fibroblasts (15) . The primary response to injury is the aggregation ofplatelets in capillaries at the edge of the wound (16) and it has been shown in vitro that PGF2. and PGE2 are released on aggregation (17) .
However, a causal relationship between release of the PGs and fibroblastic proliferation in vivo has not yet been established.
It has been shown in resting confluent cultures of Swiss 3T3
and other fibroblastic cells that PGF2a can stimulate chromosomal DNA replication and cell division (18) (19) (20) . In particular, Swiss 3T3 cells have provided a useful model system to study how PGF2a alone or with modulating hormones regulates cell proliferation (4) . Here ,ug/ml and penicillin at 100 units/ml (4 (4, 20) . Three days after seeding, the cells were given fresh medium supplemented as before and then allowed to become confluent and quiescent for 3 to 4 days. PGs were dissolved in ethanol and diluted so that the final concentration of ethanol in the conditioned medium was <0.05%. Cells were radioactively labeled for autoradiography by exposing the cultures to 1 AM [methyl-3H]thymidine (3 jCi/ml; 1 Ci = 3.7 X 1010 becquerels)] from the time of additions until the times indicated in each experiment. Pairs ofcultures were then processed for autoradiography (4) . The rate constant (k) for entry into S phase and the duration of the lag phase were calculated as described before (4) .
cAMP Measurement. For determination oftotal intracellular levels of cAMP, the cells were plated at 2.5 X 105 per 50-mm dish in 5 ml of culture medium as for the assay of DNA synthesis. Thirty or sixty minutes after additions, the culture medium was removed and cultures were rinsed twice within 10 sec with cold 140 mM NaCI/6.7 mM KCI/0.7 mM CaC12/0.5 mM MgCl2/0.4 mM Na2PO4/25 mM Tris HCI, pH 7.4. Then, cAMP was extracted by covering the cell monolayer with 1 ml of0.1 M HCl in 95% ethanol at 4°C and scraping the cells from the dish. The dish was rinsed with 1 ml of the same solution, and the rinse was pooled with the cell extract. After 16 hr or longer, the samples were centrifuged at 1,060 X g for 20 min at 4°C. The clear supernatants were evaporated to dryness on a 60°C water bath using an airstream. The dried extracts were suspended in radioimmunoassay buffer (New England Nuclear kit for determining cAMP by radioimmunoassay) and assayed in duplicate for cAMP (22 PGE1, at 2 ng-1 pug/ml, added to cells stimulated by PGF2, (300 ng/ml) synergistically enhanced the labeling index by increasing it to 51% (Fig. 1A) . Similarly, PGE2, at the same concentration, increased the PGF2a-stimulated labeling index to 48% (Fig. 1B) . The concentration of PGE1 and PGE2 giving maximal enhancement was -20 ng/ml. Insulin further enhanced the stimulation by PGF2, with PGE1 or PGE2 to 78%
( Fig. 1 A and B ). The addition of PGE1 (100 ng/ml) and PGE2 (100 ng/ml) together to cells stimulated by PGF2a (300 ng/ml) did not further increase the enhancement produced by either PGE1 or PGE2 separately ( Table 1 ). The stimulation of DNA synthesis was also reflected in an increase in cell number 48 hr after additions (Table 1) . Neither PGFia nor PGD2 at concentrations up to 1 pug/ml had any effect on cells stimulated by PGF2a, either alone or with insulin ( Fig. 1 A and Furthermore, linoleic acid, oleic acid, and arachidonic acid (a precursor of PGs) had no effect on DNA synthesis (Table 1) .
Since physiological concentrations of PGs in normal tissues and body fluids are generally lower than the saturating concentrations for stimulating DNA synthesis in Swiss 3T3 cells, the synergistic effect ofthese PGs was studied at concentrations 1-10% of those found in various human tissues (27) . At 3 ng/ml, neither PGF2,, PGE1, nor PGE2 alone had any stimulatory effect on quiescent cells within 28 hr (Fig. 1 and Table   2 ). PGF2. together with either PGE1 or PGE2 had a very small effect (about 2% labeled nuclei). However, in the presence of a low concentration of insulin (6 ng/ml), this marginal stimulation was enhanced to 11%. For PGF2., PGE1, and PGE2 each added alone at 6 ng/ml, only PGF2. showed some stimulatory activity with insulin ( Table 2 ). Addition of PGE1 or PGE2 together with PGF2,, all at 6 ng/ml, had a synergistic effect resulting in a labeling index of =8%, which was further enhanced by insulin to =23% within 28 hr. Thus, at these low concentrations, PGF2, together with insulin and PGE1 or PGE2 stim- ulates quiescent confluent Swiss 3T3 cells to initiate DNA synthesis. Adding both PGE1 and PGE2 together with PGF2a, alone or with insulin, at these low concentrations did not further increase the effect produced by PGE1 or PGE2 alone ( Table 2) .
Addition of either PGE1 or PGE2 at 100 ng/ml reduced the saturating concentration of PGF2. required to maximally stimulate DNA synthesis from -200 to 30 ng/ml (Fig. 2) . In the presence ofinsulin and PGE1 or PGE2, concentrations of PGF2 as low as 2 ng/ml were sufficient to increase the labeling index to --30% after 28 hr. PGF2, stimulates DNA synthesis by regulating two different parameters: (i) the length of the lag phase (=15 hr) and (ii) the rate ofinitiation of DNA synthesis, which follows apparent firstorder kinetics. The latter process is quantified by a rate constant k (4). How do PGE1 and PGE2 modulate the stimulation ofDNA synthesis? The synergistic effect ofPGE1 and PGE2 was due to a marked increase in the rate of entry into S without changing the length of the lag phase ( Fig. 3 A and B) . PGE1 or PGE2 can also be added 9 or 15 hr into the lag phase, but then the synergistic effect was less than that observed when either was added together with PGF2.. However, when PGE1 or PGE2 was added at 15 hr, the time required to increase the initial PGF2 -induced rate was :5 hr.
Insulin did not change the pattern of interaction of PGE1 or PGE2 with PGF2a, although it increased the rate of entry into S phase. Adding PGE1 or PGE2 9 hr after PGF2a and insulin, however, resulted in the same rate constant as ifPGE1 or PGE2 had been added with PGF2 and insulin ( Fig. 3 C and D) . A similar enhancement was observed when PGE1 or PGE2 was added 15 hr after PGF2, and insulin, yet 5 hr were required to increase the rate induced by PGF2, and insulin.
Changes in Intracellular Levels of cAMP and 2-Deoxyglucose Uptake. In some cellular systems a predominant effect of PGE1 is to increase the intracellular levels ofcAMP. PGF2. induces the protein synthesis-dependent phase of2-deoxyglucose uptake in Swiss 3TM cells (4, 25) . A question as to the mechanism by which these PGs act is whether the synergistic effect ofPGE1 and PGE2 with PGF2. on initiation of DNA synthesis is expressed through these two biochemical events. Neither PGF2., insulin, nor PGF2. and insulin together increased the intracellular cAMP levels measured after 30 and 60 min, and fetal calf serum transiently reduced the cAMP level (Table 3) The synergistic interaction of PGF2, and insulin is observed in the stimulation of the protein synthesis-dependent phase of 2-deoxyglucose uptake measured 6 hr after additions (4, 25) (Table 3 ). Both PGE1 and PGE2 had only marginal effects on 2-deoxyglucose uptake, and only an additive effect was observed together with insulin (Table 3 ). In contrast, both PGE1 and PGE2 had synergistic effects with PGF2, on 2-deoxyglucose uptake that were further enhanced by insulin. As observed for DNA synthesis, adding PGE1 and PGE2 together with PGF2, 100 (Table 2) , and 1-100 AM 8-bromo-cAMP had no effect on DNA synthesis stimulated by PGF2,,, and insulin (data not shown). In contrast, high concentrations of PGE1 (40 Ag/ml), which increase intracellular cAMP to levels similar to those observed at low concentrations, or 8-bromo-cAMP at 1 mM inhibited the stimulation of DNA synthesis (ref. 4 ; data not shown). Thus, there appears to be no correlation between the early transient change in intracellular cAMP level and the regulation of rate of entry into S phase by PGs in Swiss 3T3 cells. This is in agreement with a recent report that, under different culture conditions, insulin, epidermal growth factor, and fibroblast-derived growth factor, which stimulated DNA synthesis, did not increase cAMP'levels by themselves (30) .
The observation that both PGE1 and PGE2 act synergistically with PGF2. suggests that PGF2, acts through different mechanisms than PGE, and PGE2 and that PGF2,,, interacts with a receptor that is distinct from that with which PGE1 and PGE2
interact. Indeed, different receptors for PGF2a and PGE have been demonstrated on bovine corpora lutea cells (6) . 'Furthermore, PGE receptors have high and low affinity sites, which preferably bind PGE1 in a fibroblastic cell line (6) . From the results with cAMP and 2-deoxyglucose, it is not apparent whether, in Swiss 3T3 cells, PGE1 and PGE2 act through different receptors or share a common receptor with different binding affinities.
The synergy between PGs may be an important mechanism involved in growth control of normal fibroblastic cells and uncontrolled growth of certain transformed cells. Normal fibroblastic growth leads to the formation of connective tissue, which, in the wound-healing process, results in a scar (15) . Wounding leads to platelet aggregation on the blood vessel wall (16) . Within 5 min after experimental induction of platelet aggregation by thrombin, PGF2, and PGE2 are released to concentrations of =10 and 35 ng/ml, respectively (17) . The experiments presented in this paper show that these concentrations are high enough to stimulate proliferation and migration of fibroblasts (unpublished results) derived from tissue adjacent to a wound (15) . In the presence ofother hormones such as insulin this stimulation could be synergistically enhanced.
It has been postulated that transformed cells proliferate independently of serum factors because they are constitutively stimulated by polypeptide growth factors produced by themselves (31, 32) . Since a number ofcancer and transformed cells show a high production of PGs (5, 14) , this may provide an alternative mechanism to bypass the normal controls of cell proliferation. Our results provide the framework for a hypothesis to study the role ofPGs in the control ofproliferation ofnormal and transformed. cells. 
